Skip to content

Phage Safety Retrospective Cohort Study

Phage Safety Retrospective Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04724603
Acronym
PHASACO-retro
Enrollment
25
Registered
2021-01-26
Start date
2021-02-01
Completion date
2026-09-01
Last updated
2023-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone and Joint Infection, Prosthetic Joint Infection

Keywords

bone and joint infection, phagotherapy, adverse event, Prosthetic Joint Infection

Brief summary

The aim of this study is to determine the imputability of adverse events in patients who have had phage therapy for the treatment of their bone or joint or implant infection, in order to find out whether these adverse effects are related to surgery, antibiotic treatment or bacteriophages.

Interventions

OTHERpatients having had avderse event after phagotherapy for bone or joint or implant infection

to determine the accountability of adverse effects in having had avderse event after phagotherapy for bone or joint or implant infection

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

* patients having had a bone or joint or implant infection treated by phagotherapy and having had an adverse event

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
rate of patients having had an adverse event1 yearnumber of patients having had an adverse event
rate of adverse event attributable to the surgery1 yearnumber of patients having had an adverse event because of the surgery
type of adverse event attributable to the surgery1 yearclassification according to Clavien's Clasification
rate of adverse event attributable to the antibiotic treatment1 yearnumber of patients having had an adverse event because of the antibiotic treatment
rate of adverse event attributable to the phagotherapy1 yearnumber of patients having had an adverse event because of phagotherapy

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026